Sulfasalazine is a potential treatment for IgA-vasculitis (Henoch-Schönlein Purpura), according to Russian researchers who tested the drug in a small trial and found that most patients experienced complete remission of arthritis and skin rash. Dr Sergei Giliaev and colleagues from the First Moscow State Medical University decided to investigate sulfasalazine in patients with IgA-vasculitis because ...
Sulfasalazine shows promise as a potential treatment for IgA-vasculitis
By Ingrid Torjesen
19 Jun 2018